Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-25-092603
Filing Date
2025-07-02
Accepted
2025-07-02 11:18:19
Documents
53
Period of Report
2025-07-02

Document Format Files

Seq Description Document Type Size
1 6-K pr_-_esmo_gi_-_7-02-25.htm 6-K 29847
2 EX-99.1 imab-ex99_1.htm EX-99.1 86523
3 EX-99.2 imab-ex99_2.htm EX-99.2 11431
4 EX-99.3 imab-ex99_3.htm EX-99.3 55070
5 GRAPHIC img44095488_0.jpg GRAPHIC 40503
6 GRAPHIC imab-ex99_2s1.jpg GRAPHIC 339561
7 GRAPHIC imab-ex99_2s2.jpg GRAPHIC 264262
8 GRAPHIC imab-ex99_2s3.jpg GRAPHIC 356589
9 GRAPHIC imab-ex99_2s4.jpg GRAPHIC 395748
10 GRAPHIC imab-ex99_2s5.jpg GRAPHIC 411675
11 GRAPHIC imab-ex99_2s6.jpg GRAPHIC 540702
12 GRAPHIC imab-ex99_2s7.jpg GRAPHIC 327222
13 GRAPHIC imab-ex99_2s8.jpg GRAPHIC 365309
14 GRAPHIC imab-ex99_2s9.jpg GRAPHIC 391062
15 GRAPHIC imab-ex99_2s10.jpg GRAPHIC 215043
16 GRAPHIC imab-ex99_3s1.jpg GRAPHIC 188879
17 GRAPHIC imab-ex99_3s2.jpg GRAPHIC 985548
18 GRAPHIC imab-ex99_3s3.jpg GRAPHIC 329460
19 GRAPHIC imab-ex99_3s4.jpg GRAPHIC 562569
20 GRAPHIC imab-ex99_3s5.jpg GRAPHIC 454659
21 GRAPHIC imab-ex99_3s6.jpg GRAPHIC 451930
22 GRAPHIC imab-ex99_3s7.jpg GRAPHIC 424663
23 GRAPHIC imab-ex99_3s8.jpg GRAPHIC 317984
24 GRAPHIC imab-ex99_3s9.jpg GRAPHIC 393097
25 GRAPHIC imab-ex99_3s10.jpg GRAPHIC 404407
26 GRAPHIC imab-ex99_3s11.jpg GRAPHIC 372800
27 GRAPHIC imab-ex99_3s12.jpg GRAPHIC 508532
28 GRAPHIC imab-ex99_3s13.jpg GRAPHIC 422044
29 GRAPHIC imab-ex99_3s14.jpg GRAPHIC 426770
30 GRAPHIC imab-ex99_3s15.jpg GRAPHIC 363612
31 GRAPHIC imab-ex99_3s16.jpg GRAPHIC 318860
32 GRAPHIC imab-ex99_3s17.jpg GRAPHIC 406138
33 GRAPHIC imab-ex99_3s18.jpg GRAPHIC 383586
34 GRAPHIC imab-ex99_3s19.jpg GRAPHIC 521246
35 GRAPHIC imab-ex99_3s20.jpg GRAPHIC 440818
36 GRAPHIC imab-ex99_3s21.jpg GRAPHIC 316211
37 GRAPHIC imab-ex99_3s22.jpg GRAPHIC 331620
38 GRAPHIC imab-ex99_3s23.jpg GRAPHIC 269312
39 GRAPHIC imab-ex99_3s24.jpg GRAPHIC 297311
40 GRAPHIC imab-ex99_3s25.jpg GRAPHIC 298671
41 GRAPHIC imab-ex99_3s26.jpg GRAPHIC 424008
42 GRAPHIC imab-ex99_3s27.jpg GRAPHIC 387234
43 GRAPHIC imab-ex99_3s28.jpg GRAPHIC 359022
44 GRAPHIC imab-ex99_3s29.jpg GRAPHIC 264008
45 GRAPHIC imab-ex99_3s30.jpg GRAPHIC 436330
46 GRAPHIC imab-ex99_3s31.jpg GRAPHIC 304531
47 GRAPHIC imab-ex99_3s32.jpg GRAPHIC 385690
48 GRAPHIC imab-ex99_3s33.jpg GRAPHIC 424902
49 GRAPHIC imab-ex99_3s34.jpg GRAPHIC 167491
50 GRAPHIC imab-ex99_3s35.jpg GRAPHIC 450691
51 GRAPHIC imab-ex99_3s36.jpg GRAPHIC 459398
52 GRAPHIC imab-ex99_3s37.jpg GRAPHIC 408307
53 GRAPHIC imab-ex99_3s38.jpg GRAPHIC 198776
  Complete submission text file 0000950170-25-092603.txt   25668478
Mailing Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850
Business Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850 (301) 670 2800
I-Mab (Filer) CIK: 0001778016 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39173 | Film No.: 251099012
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)